江苏和晨药业

Jiangsu Hechen Pharmaceutical is a comprehensive pharmaceutical enterprise located in the China Medical City of Taizhou, Jiangsu Province. Founded in 2011, the company specializes in the research, development, and large-scale production of chemical APIs and finished dosage forms. Its primary therapeutic focus includes metabolic diseases, cardiovascular conditions, and anti-infectives, with a strong portfolio of high-end generic medications such as DPP-4 inhibitors and anticoagulants. Hechen operates state-of-the-art GMP manufacturing facilities and is increasingly investing in the development of innovative small molecule drugs. The company aims to provide affordable, high-quality healthcare solutions for both the Chinese domestic market and global partners.